Icahn's opposition to Express Scripts merger is 'misguided and short-sighted,' Cigna says
August 07, 2018 at 18:20 PM EDT
Cigna defended the deal, saying it would "create tremendous value for shareholders, accelerate the transformation of healthcare and address the dynamic regulatory environment for health services."